Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nourianz for motor complications in Parkinson's disease
NCT00456586Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Apr 2002
- Primary completion
- May 2003
- Countries
- 1
01
Overview
A Phase 2 trial of safinamide in Parkinson's disease (PD), sponsored by Kyowa Kirin. Started Apr 2002; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00456586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456586.